Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug ...

Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

Shares in the company dived after a new anti-obesity treatment missed expectations in a study, denting its chances of ...

The 6,000 LB Diaries with Dr. Now promises a raw and emotional look into the lives of people facing the challenges of extreme weight loss and thus inspiring many to walk the path to stay fit.

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved for ...

Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...

According to 2017 to 2018 National Health and Nutrition Examination Survey results, 42.5% of U.S. adults 20 years old and over have obesity. Older data from the same survey states that adults with ...

Objective Obesity and hypertension (HTN) have become increasingly prevalent in Taiwan. People with obesity are more likely to have HTN. In this study, we evaluated several anthropometric measurements ...

Obesity is a complex illness which requires an understanding of multiple treatment modalities. We are committed to reduce the stigma around obesity. In this unique and world-leading MSc, you explore ...

"We saw that the children born to mothers with PCOS generally had more central obesity, meaning they were larger around the waist," said Vanky. Other studies have shown that children born to ...